Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9917878.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations LtdfiledCriticalImperial College Innovations Ltd
Priority to GBGB9917878.2ApriorityCriticalpatent/GB9917878D0/en
Publication of GB9917878D0publicationCriticalpatent/GB9917878D0/en
Priority to JP2001512562Aprioritypatent/JP2003506327A/en
Priority to CA002379237Aprioritypatent/CA2379237A1/en
Priority to EP00951682Aprioritypatent/EP1200469A2/en
Priority to BR0012765-5Aprioritypatent/BR0012765A/en
Priority to PCT/GB2000/002873prioritypatent/WO2001007479A2/en
Priority to AU64542/00Aprioritypatent/AU780414B2/en
Priority to NO20020207Aprioritypatent/NO20020207L/en
Peptide, methods of making an antibody, making a binding agent capable of binding to a cell form of a prion protein, removing a cell form of a prion protein from a sample, and using an antibody and / or binding agent, antibody, binding agent, use of an antibody or binding agent, kit, and, peptide sequence of a cellular form of a prion protein